Vijay Potluri
13Patents
3h-index
32Co-inventors
56Inventor score
Filing activity: Jun 30, 2006 → Jan 24, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9382277B2 | Pyrimido-pyridazinone compounds and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US9499495B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Physics | 3 | Active |
| US8729079B2 | Pyrimido-pyridazinone compounds and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US8080668B2 | Thiazoles derivatives as AMPK activator | Human Necessities | 1 | Active |
| US10183944B2 | Pyrimido-pyridazinone compounds and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US9487510B2 | Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists | Chemistry; Metallurgy | 1 | Active |
| US10647720B2 | Pyrimido-pyridazinone compounds and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US10226468B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Physics | 0 | Active |
| US10869872B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | General | 0 | Revoked |
| US9757382B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Physics | 0 | Active |
| US10131655B2 | Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists | Chemistry; Metallurgy | 0 | Active |
| US9303027B2 | Kappa opioid receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US10912779B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.